CRP and plasma cell myeloma: We excluded 31 subjects who had either infection (under treatment for mycobacterium tuberculosis, n = 3), malignancy (lung, colon, prostate, tonsill cancer, multiple myeloma or malignant lymphoma; n = 6) or elevated serum CRP levels (>0.5 mg/dl, n = 26), with some overlaps.